Role of CD47 as a marker of self on red blood cells

Science

Volumn 288, Issue 5473, 2000, Pages 2051-2054

  Oldenborg, Per Arne ^a   Zheleznyak, Alex ^a   Fang, Yi Fu ^a   Lagenaur, Carl F ^b   Gresham, Hattie D ^c   Lindberg, Frederik P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD47 ANTIGEN; REGULATOR PROTEIN;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; HOST CELL; MACROPHAGE; MOLECULAR RECOGNITION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANEMIA, HEMOLYTIC; ANIMALS; ANTIGENS, CD; ANTIGENS, CD47; ANTIGENS, DIFFERENTIATION; CARRIER PROTEINS; CLODRONIC ACID; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; FEMALE; HUMANS; LIPOSOMES; MACROPHAGES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; NEURAL CELL ADHESION MOLECULE L1; NEURAL CELL ADHESION MOLECULES; PHAGOCYTOSIS; PHOSPHORYLATION; RECEPTORS, IMMUNOLOGIC; SELF TOLERANCE; SIGNAL TRANSDUCTION; SPLEEN;

ANIMALIA; MURINAE;

EID: 0034674421     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.288.5473.2051     Document Type: Article

References (37)

1. L. L. Lanier, Annu. Rev. Immunol. 16, 359 (1998).
2. W. M. Yokoyama, Curr. Biol. 7, 110 (1995).
3. H. G. Ljunggren and K. Kärre, J. Exp. Med. 162, 1745 (1985).
4. E. O. Long, Annu. Rev. Immunol. 17, 875 (1999).
5. P. Höglund et al., Eur. J. Immunol. 28, 370 (1998).
6. J. Samaridis and M. Colonna, Eur. J. Immunol. 27, 660 (1997).
7. M. Colonna, F. Navarro, M. López-Botet, Curr. Top. Microbiol. Immunol. 244, 115 (1999).
8. A. Kharitonenkov et al, Nature 386, 181 (1997).
9. P. Jiang, C. F. Lagenaur, V. Narayanan, J. Biol. Chem. 274, 559 (1999).
10. E. J. Brown, L. Hooper, T. Ho, H. D. Gresham, J. Cell Biol. 111, 2785 (1990).
11. F. P. Lindberg, H. D. Gresham, E. Schwarz, E. J. Brown, J. Cell Biol. 123, 485 (1993).
12. F. P. Lindberg et al, J. Biol. Chem. 269, 1567 (1994).
13. I. G. Campbell, P. S. Freemont, W. Foulkes, J. Trowsdale, Cancer Res. 52, 5416 (1992).
14. W. J. Mawby, C. H. Holmes, D. J. Anstee, F. A. Spring, M. J. Tanner, Biochem. J. 304, 525 (1994).
15. F. P. Lindberg et al, Science 274, 795 (1996).
16. -/- mice (33) on a mixed 129/C56BL/6 background were a gift from H. Molina (Washington University, St. Louis, MO). Animals were kept in accordance with NIH and local guidelines and maintained in a specific pathogen-free barrier facility.
17. -/- recipients (detection by staining for CD47 and flow cytometry) gave similar results.
18. N. van Rooijen and A. Sanders, J. Immunol. Methods 174, 83 (1994).
19. N. van Rooijen, N. Kors, G. Kraal, J. Leukocyte Biol. 45, 97 (1989).
20. Dichloromethylene diphosphonate (clodronate; a gift from Roche Diagnostics/Boehringer Mannheim GmbH) liposomes was prepared as described (T8). Clodronate (200 μl) or NaCl liposomes were given to recipient mice by tail-vein injection at 48 and 24 hours before RBC transfer. Immunohistochemical analyses revealed a complete macrophage depletion in recipient spleens 48 hours after a single injection of clodronate liposomes.
21. + cells were visualized with Tyramide Signal Amplification (NEN Life Science Products, Boston, MA).
22. Y. Fujioka et al, Mol. Cell. Biol. 16, 6887 (1996).
23. S. Adams et al. J. Immunol. 161, 1853 (1998).
24. -/- RBCs were added to each well for another 60 min. Nonadherent cells were washed off with warm phosphate-buffered saline (PBS)-0.1% HSA, and noningested RBCs were lysed with ACK lysis buffer. Phagocytosis index (the number of RBCs phagocytosed per 100 adherent macrophages) was determined by fluorescence microscopy (Zeiss Axioscope).
25. A. Veillette, E. Thibaudeau, S. Latour, J. Biol. Chem. 273, 22719 (1998).
26. W. H. Fridman, P. Bruhns, O. Malbec, M. Daëron, J. Biol. Chem. 274, 32493 (1999).
27. -/- RBCs were added, then allowed to settle for 3 min at 4 °C, after which sodium pervanadate (Sigma) was added to 2 mM and cells were transferred to a water bath at 37 °C At the times indicated, the medium was quickly aspirated, and cells were lysed in cold lysis buffer [50 mM tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40 (Pierce, Rockford, IL), 1 mM diisopropyl, aprotinin (10 μg/ml), 2 mM sodium pervanadate]. Lysates were cleared by centrifugation and incubated for 2 hours at 4 °C with anti-SIRP monoclonal antibody (mAb) P84 bound to 20 μl of goat anti-rat Sepharose (ICN, Costa Mesa, CA) for 2 hours at 4 °C. After two washes in lysis buffer, immunoprecipitated proteins were eluted with reducing SDS-polyacrylamide gel electrophoresis (PACE) sample buffer, separated on 8% SDS-PACE, and transferred to a polyvinylidene difluoride membrane (Millipore, Bedford, MA). Tyrosine phosphorylation was detected by Western blot with anti-phosptiotyrosine mAb 4G10, followed by HRP-conjugated secondary antibody and enhanced chemoluminescence as described (36).
28. Reviewed in N. D. Avent and M. E. Reid, Blood 95, 375 (2000).
29. F. P. Lindberg et al., unpublished data.
30. L. G. Poels et al., J. Natl. Cancer Inst. 76, 781 (1986).
31. M. Seiffert et al. Blood 94, 3633 (1999).
32. P. Mombaerts et al., Cell 68, 869 (1992).
33. M. R. Wessels et al., Proc. Natl. Acad. Sci. U.S.A. 92, 11490 (1995).
34. M. D. Witmer and R. M. Steinman, Am. J. Anat. 170, 465 (1984).
35. G. Kraal and M. Janse, Immunology 58, 665 (1986).
36. T. Roach et al., Curl. Biol. 7, 408 (1997).
37. We thank T. Steinberg, W. Yokoyama, J. Atkinson, and E. Brown for critically reading the manuscript; D. Chaplin, H. Molina, and P. Leenen for reagents; and E. Ford for technical assistance. Supported by grants from the NIH (GM57S73-01), the American Diabetes Association, the Washington University-Monsanto Research Agreement, a pilot grant from the Howard Hughes Medical Institute, and the Medical Research Service of the Depatment of Veterans Affairs. P.-A.O is supported by a postdoctoral fellowship from the Umeå University-Washington University exchange program and by the Swedish Medical Research Council.